You are here

Singapore infrastructure a draw for pharma giants

Pharmaceutical firm AbbVie has invested S$400 million to open a manufacturing plant at Tuas Biomedical Park, to support its global manufacturing pipeline.

The Biopolis complex at Buona Vista. Today, six out of the top 10 drugs globally are made in Singapore, attesting to the city-state's success in attacting big players.

IN 50 YEARS, Singapore has undergone significant transformation from a developing country into a thriving metropolis. Today, with its robust physical and regulatory environment, global connectivity and skilled talent pool, this city-state is a multidisciplinary hub for businesses looking to...

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to